Corinna has a unique combination of senior business development and scientific expertise in the pharmaceutical and pharmaceutical services sectors. Previously, she held senior leadership roles at BioAgilytix, Pfizer, and Eyetech Pharmaceuticals. Corinna earned a PhD in Microbiology/Immunology from the University of New Hampshire and completed Post-Doctoral research in Molecular Biology at Harvard Medical School.